BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
10x Genomics
TXG
$6.61B
| $1.22B | 0.03% |
8,354,676
+805,501
| +11% | +$138M |
|
|
AXON
502
Axon Enterprise
AXON
$46.4B
| $1.21B | 0.03% |
6,939,799
+38,407
| +0.6% | +$6.98M |
|
503
Cardinal Health
CAH
$55.4B
| $1.21B | 0.03% |
24,547,669
-1,775,589
| -7% | -$96.3M |
|
504
NiSource
NI
$20.4B
| $1.21B | 0.03% |
50,054,825
+3,462,455
| +7% | +$86.3M |
|
505
Vanguard Total Bond Market
BND
$158B
| $1.21B | 0.03% |
14,148,904
-384,661
| -3% | -$33.2M |
|
506
IDEX
IEX
$17.3B
| $1.21B | 0.03% |
5,841,852
+77,725
| +1% | +$17.3M |
|
|
AVLR
507
DELISTED
Avalara, Inc.
AVLR
| $1.21B | 0.03% |
6,895,527
-24,890
| -0.4% | -$4.28M |
|
508
Jack Henry & Associates
JKHY
$11.1B
| $1.2B | 0.03% |
7,331,197
-36,892
| -0.5% | -$6.34M |
|
509
Incyte
INCY
$24.4B
| $1.2B | 0.03% |
17,411,778
+460,500
| +3% | +$35M |
|
510
Unilever
UL
$136B
| $1.2B | 0.03% |
19,606,494
+322,533
| +2% | +$20.6M |
|
511
Lumen
LUMN
$6.44B
| $1.19B | 0.03% |
96,066,147
-54,726
| -0.1% | -$686K |
|
512
Trex
TREX
$5.01B
| $1.19B | 0.03% |
11,675,678
-235,128
| -2% | -$24.6M |
|
513
Bath & Body Works
BBWI
$4.1B
| $1.18B | 0.03% |
18,788,482
-1,361,623
| -7% | -$86.6M |
|
514
BioMarin Pharmaceuticals
BMRN
$12.4B
| $1.18B | 0.03% |
15,320,799
+2,425,231
| +19% | +$191M |
|
515
Lear
LEA
$8.18B
| $1.18B | 0.03% |
7,510,215
-111,103
| -1% | -$18.2M |
|
516
Amcor
AMCR
$22.1B
| $1.17B | 0.03% |
20,230,542
+17,258
| +0.1% | +$1.03M |
|
517
Insulet
PODD
$9.79B
| $1.17B | 0.03% |
4,118,882
+19,392
| +0.5% | +$5.53M |
|
518
Celanese
CE
$4.82B
| $1.17B | 0.03% |
7,768,359
-67,490
| -0.9% | -$10.4M |
|
519
Viatris
VTRS
$18.9B
| $1.17B | 0.03% |
86,123,062
-1,614,574
| -2% | -$22.9M |
|
520
Plug Power
PLUG
$3.04B
| $1.16B | 0.03% |
45,548,919
+741,751
| +2% | +$19.9M |
|
521
Nordson
NDSN
$17.3B
| $1.16B | 0.03% |
4,884,174
-56,936
| -1% | -$13.1M |
|
522
J.M. Smucker
SJM
$12.8B
| $1.16B | 0.03% |
9,677,517
-604,039
| -6% | -$76.8M |
|
523
Textron
TXT
$15.4B
| $1.16B | 0.03% |
16,605,922
-639,015
| -4% | -$44.9M |
|
524
Hormel Foods
HRL
$13.8B
| $1.15B | 0.03% |
28,129,745
+13,088
| +0% | +$590K |
|
525
Keurig Dr Pepper
KDP
$40.8B
| $1.15B | 0.03% |
33,607,887
+3,167,455
| +10% | +$111M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.